MedTrace Logo

The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder

NCT04720040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2021-01-22

No results posted yet for this study

Summary

This study evaluated the effectiveness and safety of improving depressive symptoms by applying tDCS for 6 weeks to patients with mild to moderate depression.

Conditions

Interventions

DEVICE

Mind STIM

transcranial Direct Current Stimulation (tDCS) 2mA for 30 min; 30 sec of ramp-up and -down; left (anode) and right (cathode) Dorsolateral prefrontal cortex (DLPFC)

Sponsors & Collaborators

  • The Catholic University of Korea

    collaborator OTHER

  • Inje University

    collaborator OTHER

  • Korea University

    collaborator OTHER

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Hallym University Medical Center

    collaborator OTHER

  • Soonchunhyang University Hospital

    collaborator OTHER

  • Ybrain Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-23
Primary Completion
2020-08-31
Completion
2020-10-15

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720040 on ClinicalTrials.gov